Publication | Closed Access

LBA4 GEMSTONE-302: A phase III study of platinum-based chemotherapy (chemo) with placebo or CS1001, an anti-PDL1 antibody, for first-line (1L) advanced non-small cell lung cancer (NSCLC)

Anti-pdl1 AntibodyMedicineImmunologyPathologyImmune Checkpoint InhibitorAnti-cancer AgentPhase Iii StudyCancer TreatmentOncologyRadiation OncologyLung CancerLba4 Gemstone-302